Targeting Emotion Dysregulation to Reduce Suicide in People With Psychosis (NCT05440214)
🩺 Plain-English Summary (8th-Grade Level)
People with psychotic disorders are excluded from most suicide-focused clinical trials despite incredibly high rates of completed suicide, and interventions that have been tested for this population have shown limited impact on suicide. Emotion dysregulation is a significant suicidogenic factor that is understudied in people with psychotic disorders. The investigators propose to implement and evaluate an intervention targeting emotion dysregulation in people with psychotic disorders while employing rigorous statistical modeling and measurement techniques including Ecological Momentary Assessment, which will support future advanced research on suicide and suicide prevention for this high-risk group.
Who can join: Review the eligibility criteria below.
Location: University of Maryland — Baltimore, Maryland
Age range: 18 Years
🧪 Interventions in This Study
- Dialectical Behavior Therapy Skills Training (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- University of Maryland — Baltimore, Maryland
📞 Contact the Study Coordinator
Phone: (410) 706-2490
Email: pphalen@som.umaryland.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Psychosis
- Psychosis TMS Study — Charlestown, Massachusetts
- Youth Nominated Support Team — Irvine, California
- Trajectories of Treatment Response as Window Into the Heterogeneity of Psychosis: a Longitudinal Multimodal Imaging Study — Birmingham, Alabama
- EPI-MINN: Targeting Cognition and Motivation — Duluth, Minnesota
- Probing the Cannabinoid System in Individuals With a Family History of Psychosis — West Haven, Connecticut
- EPI-MINN: Targeting Cognition and Motivation - National — Minneapolis, Minnesota
Explore by condition: All Psychosis clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.